Understanding OUR Cytokine-Based Immunotherapy Candidates Our determination extends to advancing a robust portfolio of programs aimed at growing the horizons of cytokine-based immunotherapy, specifically for cancers where treatment choices remain limited. Use the links below to learn much more about our portfolio of cytokine-based immunotherapy candidates. Discover Our Pipeline https://financefeeds.com/polymarket-hits-record-450k-traders-despite-election-cycle-ending/